Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Merigan

Showing results (151-160 of 366) with videos related to

Pageof 37
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1980
Role of G0-G1 arrest in the inhibition of tumor cell growth by interferonA A Creasey, J C Bartholomew, T C Merigan
Lancet (London, England)|February 23, 1980
Interferon in chronic hepatitis B infectionT C Merigan, W S Robinson, P B Gregory
Cellular Immunology|October 15, 1984
Interferon enhances antibody-dependent cellular cytotoxicity when suboptimal concentrations of antibody are usedT Y Basham, W K Smith, T C Merigan
The Journal of Infectious Diseases|July 1, 1974
Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infectionG W Jordan, R P Fried, T C Merigan
Cellular Immunology|December 1, 1971
PPD-stimulated interferon: in vitro macrophage-lymphocyte interaction in the production of a mediator of cellular immunityL B Epstein, M J Cline, T C Merigan
The American Journal of Medicine|September 1, 1976
Diagnosis of cytomegalovirus pneumonia in compromised hostsP S Abdallah, J B Mark, T C Merigan
Infection and Immunity|April 1, 1971
Effect of Separate and Combined Injections of Poly rI: Poly rC and Endotoxin on Reticulo-endothelial Activity, Interferon, and Antibody Production in the MouseT J Chester, E de Clercq, T C Merigan
The Journal of Clinical Investigation|April 1, 1971
The interaction of human macrophages and lymphocytes in the phytohemagglutinin-stimulated production of interferonL B Epstein, M J Cline, T C Merigan
Antiviral Research|April 1, 1990
Physical and biological characterization of antigen presenting liposome formulations: relative efficacy for the treatment of recurrent genital HSV-2 in guinea pigsR J Ho, R L Burke, T C Merigan
Virology|August 1, 1985
Human cytomegalovirus polypeptides stimulate neutralizing antibody in vivoL Rasmussen, J Mullenax, M Nelson, et al.
Pageof 37

Showing results (151-160 of 366) with videos related to

Sort By:
Pageof 37
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1980
Role of G0-G1 arrest in the inhibition of tumor cell growth by interferonA A Creasey, J C Bartholomew, T C Merigan
Lancet (London, England)|February 23, 1980
Interferon in chronic hepatitis B infectionT C Merigan, W S Robinson, P B Gregory
Cellular Immunology|October 15, 1984
Interferon enhances antibody-dependent cellular cytotoxicity when suboptimal concentrations of antibody are usedT Y Basham, W K Smith, T C Merigan
The Journal of Infectious Diseases|July 1, 1974
Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infectionG W Jordan, R P Fried, T C Merigan
Cellular Immunology|December 1, 1971
PPD-stimulated interferon: in vitro macrophage-lymphocyte interaction in the production of a mediator of cellular immunityL B Epstein, M J Cline, T C Merigan
The American Journal of Medicine|September 1, 1976
Diagnosis of cytomegalovirus pneumonia in compromised hostsP S Abdallah, J B Mark, T C Merigan
Infection and Immunity|April 1, 1971
Effect of Separate and Combined Injections of Poly rI: Poly rC and Endotoxin on Reticulo-endothelial Activity, Interferon, and Antibody Production in the MouseT J Chester, E de Clercq, T C Merigan
The Journal of Clinical Investigation|April 1, 1971
The interaction of human macrophages and lymphocytes in the phytohemagglutinin-stimulated production of interferonL B Epstein, M J Cline, T C Merigan
Antiviral Research|April 1, 1990
Physical and biological characterization of antigen presenting liposome formulations: relative efficacy for the treatment of recurrent genital HSV-2 in guinea pigsR J Ho, R L Burke, T C Merigan
Virology|August 1, 1985
Human cytomegalovirus polypeptides stimulate neutralizing antibody in vivoL Rasmussen, J Mullenax, M Nelson, et al.
Pageof 37